Details

Autor(en) / Beteiligte

• Igarashi, Chika
• Yoshii, Yukie
• Tashima, Hideaki
• Iwao, Yuma
• Sakurai, Kohei
• Hihara, Fukiko
• Tachibana, Tomoko
• Yoshida, Eiji
• Wakizaka, Hidekatsu
• Akamatsu, Go
• Yamaya, Taiga
• Yoshimoto, Mitsuyoshi
• Matsumoto, Hiroki
• Zhang, Ming-Rong
• Nagatsu, Kotaro
• Sugyo, Aya
• Tsuji, Atsushi B
• Higashi, Tatsuya

Titel

Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer

Ist Teil von

• Nuclear medicine communications, 2021-10, Vol.42 (10), p.1112

Ort / Verlag

England

Erscheinungsjahr

2021

Link zum Volltext

Beschreibungen/Notizen

• In pancreatic cancer surgery, accurate identification and resection of intrapancreatic residual tumors are quite difficult. We have developed a novel open-typed PET system (called 'OpenPET'), which enables high-resolution PET-guided surgery in real time, and demonstrated that OpenPET-guided surgery with intraperitoneally administered 64Cu-labeled anti-epidermal growth factor receptor antibody cetuximab is useful to detect and resect primary pancreatic cancer. Here, we investigated applicability of OpenPET-guided surgery for unexpected residual intrapancreatic tumors and examined its survival benefit over conventional surgery. A mouse model with large (>1 cm) resectable pancreatic cancer of xPA-1-DC cells expressing red fluorescent protein was used. OpenPET-guided surgery was conducted 24 h after intraperitoneal administration of 64Cu-labeled cetuximab (7.4 MBq/mouse). For comparison, similar surgical procedures were conducted, and conventional tumor resection was attempted using only the naked eye (control). Survival rate after OpenPET-guided surgery was compared to that after control operations. Intraoperative OpenPET guidance enabled detection and resection of small residual tumors. Ten residual tumor specimens (3-10 mm in diameter) were intraoperatively isolated with OpenPET guidance (n = 7 mice). All isolated specimens showed tumor RFP signals. No resection of tumor tissue was performed in control group because the tumor could not be clearly detected with the naked eye alone. Mice after OpenPET-guided surgery showed significantly longer survival rates than those in control group. OpenPET-guided surgery with 64Cu-labeled-cetuximab enabled intraoperative identification and resection of intrapancreatic small residual tumors. This technology could be useful to prevent tumor residuals during surgery and improve pancreatic cancer survival.